-+ 0.00%
-+ 0.00%
-+ 0.00%

Celularity Regains Nasdaq Compliance

Benzinga·10/22/2026 12:06:53
Listen to the news

Celularity Inc. (Nasdaq: CELU) ("Celularity"), a longevity-focused regenerative and cellular medicine company, today announced that it received written confirmation from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") that Celularity has regained compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic financial reports with the U.S. Securities and Exchange Commission.